Gilead to buy cancer drugmaker Immunomedics for $21 billion – Yahoo Finance
Business News
- Gilead to buy cancer drugmaker Immunomedics for $21 billion Yahoo Finance
- Gilead to acquire Immunomedics for $21 billion CNN
- Gilead to buy cancer drugmaker Immunomedics in $21 billion deal CNBC
- Gilead’s $21 Billion Deal Splurge May End in Regret Bloomberg
- Inside Gilead’s $21 billion purchase of Immunomedics: Lamb chops, steak, and a chance for transformation STAT
- View Full Coverage on Google News
Source: Business News